Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03838198 · ClinicalTrials.gov registry record · NA
An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT03838198: Completed NA study, sponsored by University of Michigan.
NCT03838198 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 82 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03838198, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
To inform the development of a technology-augmented adaptive intervention for adolescents at risk for suicide, the goal of this study is to conduct a Sequential, Multiple Assignment, Randomized Trial (SMART) pilot of a Motivational Interview (MI)-enhanced safety planning intervention (MI-SafeCope). Findings from this study will provide the groundwork for the construction of a technology-augmented adaptive intervention that could lead to a reduction in suicidal behaviors and related events during the high-risk post-discharge period-an important suicide prevention target.
Primary Outcome
Eligible participants were candidates for participation based on medical record review who were approached for consent/assent. The percentage of eligible participants who consented to the study is presented below.
Interventions
- BEHAVIORAL MI-Enhanced Safety Plan at Hospitalization (1st Component)
- BEHAVIORAL MI-Enhanced Text Boosters (2nd Component)
- BEHAVIORAL MI-Enhanced Booster Call (3rd Component)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2019-03-14 |
| Est. Completion | 2020-04-07 |
| Phase | NA |
What the finished NCT03838198 record still lists
NCT03838198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which MI-Enhanced Safety Plan at Hospitalization (1st Component) is the first listed.
NCT03838198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03838198 about?
NCT03838198 is a clinical study titled "An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART". To inform the development of a technology-augmented adaptive intervention for adolescents at risk for suicide, the goal of this study is to conduct a Sequential, Multiple Assignment, Randomized Trial (SMART) pilot of a Motivational Interview (MI)-enhanced safety planning intervention (MI-SafeCope). ...
What is the current status of trial NCT03838198?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2019-03-14. Estimated completion is 2020-04-07.
What interventions are being tested in trial NCT03838198?
The interventions under investigation include: MI-Enhanced Safety Plan at Hospitalization (1st Component) (BEHAVIORAL), MI-Enhanced Text Boosters (2nd Component) (BEHAVIORAL), MI-Enhanced Booster Call (3rd Component) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03838198?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03838198's enrollment target sits among peer trials
82 990th of 2000 higher than 1,009 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI